When all OM patients were combined, anti-Ro52/TRIM21 were also significantly more common in OM than in pure DM (n = 22/66, 33% vs n = 2/24, 8%) (p = 0.017, OR 5.5, 95% CI 1.18 to 25.5). This evidence concerns the gene TRIM21 and dermatomyositis.